Related references
Note: Only part of the references are listed.Aggressive Surgery in Retroperitoneal Soft Tissue Sarcoma Carried Out at High-Volume Centers is Safe and is Associated With Improved Local Control
Sylvie Bonvalot et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Jordi Barretina et al.
NATURE GENETICS (2010)
Predicting Outcome by Growth Rate of Locally Recurrent Retroperitoneal Liposarcoma The One Centimeter Per Month Rule
James O. Park et al.
ANNALS OF SURGERY (2009)
Clinical and Biological Significance of CDK4 Amplification in Well-Differentiated and Dedifferentiated Liposarcomas
Antoine Italiano et al.
CLINICAL CANCER RESEARCH (2009)
Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma
Samuel Singer et al.
CANCER RESEARCH (2007)
Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma
TM Pawlik et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes -: A comparative analysis of 559 soft tissue neoplasms with genetic data
MBN Binh et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
From the archives of the AFIP - Imaging of musculoskeletal liposarcoma with radiologic-pathologic correlation
MD Murphey et al.
RADIOGRAPHICS (2005)
Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators:: recognition of new variants and differential diagnosis
JM Meis-Kindblom et al.
VIRCHOWS ARCHIV (2001)
Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
SY Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
